The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial ...
Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.
Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback